TAFASITAMAB in the United States
5 medicine records from 3 holders carry this name in the official sources. Collected on November 10, 2026.
Medicines
| Name | Holder | Code |
|---|---|---|
| MONJUVI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Incyte Corporation |
Product NDC
50881-013Package NDC
50881-013-03
|
| MONJUVI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Incyte Corporation |
Product NDC
73535-208Package NDC
73535-208-01
|
| tafasitamab SOLUTION | Boehringer Ingelheim Pharma GmbH and Co. KG |
Product NDC
12714-212Package NDC
12714-212-40
|
| Tafasitamab POWDER | Boehringer Ingelheim Pharma GmbH and Co. KG |
Product NDC
12714-219Package NDC
12714-219-40
|
| Tafasitamab LIQUID | Lonza Biologics, Inc. |
Product NDC
67643-0029Package NDC
67643-0029-1
|
Need this list in your own system?
Every record on this page is available through the API, with its source, licence and retrieval date.